Stoke Therapeutics (STOK) Revenue (2022 - 2026)
Stoke Therapeutics (STOK) posted quarterly Revenue of $6.2 million for Q1 2026, down 96.07% year-over-year from $158.6 million in Q1 2025, and up 344.29% quarter-over-quarter from $1.4 million in Q4 2025.
Stoke Therapeutics (STOK) Revenue (2022 - 2026) Analysis & Trends
Stoke Therapeutics' Revenue history runs 5 years deep, the most recent figure standing at $6.2 million for Q1 2026.
- In Q1 2026, Revenue fell 96.07% year-over-year to $6.2 million; the TTM figure through Mar 2026 stood at $32.1 million (down 83.2% YoY), while the FY2025 annual figure was $184.4 million, up 404.5% from the prior year.
- Revenue for Q1 2026 stood at $6.2 million, up from $1.4 million in the prior quarter.
- The five-year high for Revenue was $158.6 million in Q1 2025, with the low at $1.4 million in Q4 2025.
- The 5-year median for Revenue is $4.2 million (2024), against an average of $14.9 million.
- The sharpest annual moves came in 2025 and 2026: Revenue soared 3661.12% in 2025, then sank 96.07% in 2026.
- Stoke Therapeutics' Revenue stood at $3.3 million in 2022, then fell by 14.26% to $2.8 million in 2023, then surged by 707.07% to $22.6 million in 2024, then plunged by 93.8% to $1.4 million in 2025, then surged by 344.29% to $6.2 million in 2026.
- Business Quant data shows STOK's Revenue at $6.2 million in Q1 2026, $1.4 million in Q4 2025, and $10.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.56 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.71 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,001.92 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 674.14 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.29 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Stoke Therapeutics | 1.95 Bn | 1.66 Bn | - | 9.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.33 Mn |
| Mar 31, 2026 | 6.23 Mn |
| Dec 31, 2025 | 1.40 Mn |
| Sep 30, 2025 | 10.63 Mn |
| Jun 30, 2025 | 13.82 Mn |
| Mar 31, 2025 | 158.57 Mn |
| Dec 31, 2024 | 22.61 Mn |
| Sep 30, 2024 | 4.89 Mn |
| Jun 30, 2024 | 4.83 Mn |
| Mar 31, 2024 | 4.22 Mn |
| Dec 31, 2023 | 2.80 Mn |
| Sep 30, 2023 | 3.31 Mn |
| Jun 30, 2023 | 2.48 Mn |
| Mar 31, 2023 | 5.15 Mn |
| Dec 31, 2022 | 3.27 Mn |
| Sep 30, 2022 | 2.91 Mn |
| Jun 30, 2022 | 3.23 Mn |
| Mar 31, 2022 | 3.00 Mn |